FM
ADVM

Frazier Management’s Adverum Biotechnologies ADVM Stock Holding History

Frazier Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-143,703
Closed -$14.2M – 35
2021
Q1 		$14.2M Hold
143,703
– – 1.14% 19
2020
Q4 		$15.6M Hold
143,703
– – 1.2% 18
2020
Q3 		$14.8M Hold
143,703
– – 1.33% 14
2020
Q2 		$30M Buy
143,703
+15,870
+12% +$2.81M 2.63% 10
2020
Q1 		$12.5M Buy
127,833
+100,999
+376% +$11.8M 1.42% 10
2019
Q4 		$3.09M Buy
+26,834
New +$2.37M 0.52% 17

Other funds holding ADVM

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Frazier Management's ADVM Position: Q2 2021 in Review

Frazier Management sold out of Adverum Biotechnologies (ADVM) in Q2 2021, closing a stake of 143,703 shares — an estimated $14.2M sold.

Frazier Management first reported a position in ADVM in Q4 2019 and held it in 6 quarters. The position peaked at $30M in Q2 2020. 118 funds tracked by Wall St. Rank hold ADVM as of Q2 2021.

  • Frazier Management reported no remaining Adverum Biotechnologies position as of Q2 2021 after selling out during the quarter.
  • Frazier Management sold 143,703 Adverum Biotechnologies shares in Q2 2021, an estimated $14.2M.
  • Frazier Management first reported a position in Adverum Biotechnologies in Q4 2019 and held it in 6 quarters.
  • Frazier Management's Adverum Biotechnologies position peaked at $30M in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2021.

Based on Frazier Management's 13F filing for Q2 2021, filed 11 Aug 2021.